First AD

Second AD

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Neoadjuvant HER2+

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

Multiple Myeloma

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

ASCO 2018 News

OncLive News Network®

Practice Changes for Use of Immunotherapy in NSCLC

OncLive News Network On Location: In Chicago Friday, June 1

OncLive News Network On Location: In Chicago Saturday, June 2

OncLive News Network On Location: In Chicago Sunday, June 3

OncLive News Network On Location: In Chicago Monday, June 4

ASCO 2018: Dr. Borghaei Highlights Immunotherapy Findings in Lung Cancer

ASCO 2018: Dr. Esteva Highlights CDK4/6 Inhibitors and More in Breast Cancer

ASCO 2018: Dr. Burris Highlights TAILORx and More in Breast Cancer

ASCO 2018: Dr. Lonial Highlights CAR T-Cell Therapy and More in Myeloma

ASCO 2018: Dr. Weber Highlights Exciting Abstracts in Melanoma

ASCO 2018: Dr. Coleman Shares Insight on Ongoing Research in Ovarian Cancer

ASCO 2018: Dr. Bekaii-Saab Highlights Pancreatic Cancer Abstracts

ASCO 2018: Dr. Birrer on Practice-Changing Ovarian Cancer Studies

ASCO 2018: Dr. Westin Sheds Light on PARP Inhibitor Abstracts in Ovarian Cancer

KEYNOTE Trial Data: Pembrolizumab's Role in NSCLC

Actual Use of Pembrolizumab and Chemotherapy in NSCLC

CheckMate-227: Testing Ipilimumab/Nivolumab in NSCLC

IMPower150: Implications for the Treatment of NSCLC

Important Data in the Squamous NSCLC Population 

Impact of Data on the Real-Life Treatment of NSCLC 

Tumor Mutational Burden in NSCLC: Should it be Routine?

Optimizing Immunotherapy in the NSCLC Treatment Paradigm 

Using Immunotherapy Beyond Progression in NSCLC 

Practice Changes for Use of Immunotherapy in NSCLC: Q&A 